跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NEUPRO rotigotine 2 mg/24 hr transdermal patch sachet - TGA Drug Approval Details
Approvals
/
TGA
/
NEUPRO rotigotine 2 mg/24 hr transdermal patch sachet
Approved
STANDARD
NEUPRO rotigotine 2 mg/24 hr transdermal patch sachet
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
8faafadb08aed2eb
Company
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Type
Standard
Approval Details
Approval Id
8faafadb08aed2eb
Product Name
NEUPRO rotigotine 2 mg/24 hr transdermal patch sachet
Artg Id
131370
Artg Name
NEUPRO rotigotine 2 mg/24 hr transdermal patch sachet
Sponsor
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Company Detail Path
/organization/ucb-australia-pty-ltd
Artg Date
2007-11-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-02371-3
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-02368-3
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
8faafadb08aed2eb
Type
Standard
Back to TGA Approvals